文献速递生殖医学

11 463名女性31 478枚未检测胚胎的累积活产率挑战传统反复种植失败定义

Cumulative live birth rates of 31 478 untested embryos from 11 463 women challenge traditional recurrent implantation failure definitions.
PubMed 文献 · Hum Reprod · 2025-01-01

该回顾性队列研究纳入2010年1月至2022年12月在根特大学医院行IVF/ICSI的11 463名女性共31 478次胚胎移植,采用Kaplan-Meier法联合逆概率加权分析累积活产率。结果显示未检测胚胎累积活产率随移植次数持续上升,第六次囊胚移植后达68.3%,第十次达78.0%,母体年龄显著影响所需囊胚数。

要点

  • 未检测胚胎累积活产率持续上升,第六次囊胚移植后达68.3%,第十次达78.0%。
  • 无年龄组在第八次囊胚移植前达到80%累积活产率。
  • 各年龄组第四次囊胚移植后累积活产率差异显著,<35岁为68.9%,>42岁为13.5%。

核心结论

  • 未检测胚胎的累积活产率随每次额外移植持续增加,第六次囊胚移植后达68.3%,第十次达78.0%。
  • 数据强调即使多次移植失败后仍有可能成功活产,年龄、胚胎质量、卵巢刺激反应和囊胚形成率影响结局。

研究设计与样本

  • 非干预性回顾性队列研究,纳入2010年1月至2022年12月根特大学医院11 463名女性的19 378个IVF/ICSI周期共31 478次胚胎移植。
  • 排除涉及PGT、卵母细胞捐赠、代孕及卵裂期与囊胚期混合移植的治疗。
  • 采用Kaplan-Meier法联合逆概率加权分析至活产的移植次数,并以逻辑回归评估既往移植胚胎数对后续活产率的预测价值。

主要发现

  • 累积活产率从第三次移植后51.1%(95%CI:49.2-53.0%)升至第六次囊胚移植后68.3%(95%CI:64.6-72.0%),第十次达78.0%(95%CI:69.5-86.5%)。
  • 第四次囊胚移植后累积活产率:<35岁68.9%(95%CI:65.8-71.8%),35-37岁57.6%(95%CI:50.4-64.8%),38-40岁42.9%(95%CI:37.5-48.4%),41-42岁16.3%(95%CI:10.7-21.8%),>42岁13.5%(95%CI:3.2-23.7%)。
  • 调整后逻辑回归中,每额外移植一枚胚胎的活产比值比为0.91(95%CI:0.86-1.07),未达统计学显著。
  • 女性年龄(OR=0.92;95%CI:0.91-0.93)、囊胚移植策略(OR=1.34;95%CI:1.20-1.51)及既往移植胚胎中优良质量比例(OR=1.21;95%CI:1.06-1.38)为显著预测因子。
  • 种植率与卵巢刺激反应(P=0.016)及囊胚形成率(P<0.0001)相关;达到相同既往失败囊胚移植数所需卵母细胞采集周期数不影响后续活产率。

临床怎么用

  • 作者认为,即使多次移植失败后仍可能成功活产,年龄、胚胎质量、卵巢刺激反应和囊胚形成率等多因素影响结局,为接受生育治疗的患者提供希望。

局限性

  • 结果受观察性回顾性设计限制。
  • 回归分析虽调整了潜在混杂因素,但残余混杂可能持续存在,尤其鉴于治疗间相当大的异质性。
  • 未排除与不良生殖结局相关因素的患者,因目标是评估实际临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there evidence of a plateau in the cumulative live birth rate (cLBR) after a certain number of consecutive transfers of untested embryos? SUMMARY ANSWER: In our cohort of 11 463 women, the cLBR continues to increase with each additional transfer of an untested embryo, reaching 68.3% after six blastocyst transfers and 78.0% after 10 blastocyst transfers. WHAT IS KNOWN ALREADY: While cumulative success rates in ART are rising, implantation failure remains a persistent challenge. The actual frequency of recurrent implantation failure (RIF) and whether RIF surpasses the inherent implantation potential of transferred embryos remains a matter of debate. A recent study reported a cLBR of 98% after five euploid blastocyst transfers, suggesting that most implantation failures are likely embryonic rather than endometrial. However, it remains unclear how these findings can be extrapolated to patients who did not undergo preimplantation genetic testing for aneuploidy (PGT-A). While theoretical models estimate cumulative implantation probabilities based on published blastocyst euploidy rates by female age, real-world data on cumulative success in routine clinical practice remain limited. STUDY DESIGN, SIZE, DURATION: This non-interventional retrospective cohort study included records of all completed IVF/ICSI cycles (including thus fresh and frozen-thawed transfers of one oocyte retrieval cycle) in women who underwent IVF/ICSI at the Ghent University Hospital between January 2010 and December 2022. After excluding treatments involving PGT, oocyte donation and surrogacy, or a mix of cleavage stage and blastocyst stage transfers, our dataset consisted of 11 463 women who underwent a total of 19 378 IVF/ICSI cycles, resulting in a total of 31 478 embryo transfers. PARTICIPANTS/MATERIALS, SETTING, METHODS: The number of embryos transferred ('time') until achieving live birth ('event') was analysed using a Kaplan-Meier approach with inverse probability weighting (IPW). Additionally, logistic regression analysis was conducted to assess the predictive value of the number of previously transferred embryos on the live birth rates (LBRs) of the second and subsequent transfers, adjusting for female age, quality of previously transferred embryos, and stage of embryos transferred (cleavage stage versus blastocyst stage). MAIN RESULTS AND THE ROLE OF CHANCE: Kaplan-Meier estimates using an IPW approach showed cLBRs increasing from 51.1% (95% CI: 49.2-53.0%) after a third, up to 68.3% (95% CI: 64.6-72.0%) after a sixth and even as high as 78.0% (95% CI: 69.5-86.5%) after a tenth blastocyst transfer, respectively. As maternal age increases, higher numbers of blastocysts are required to achieve the same cLBR. Moreover, no age category achieves an 80% cLBR until after the transfer of eight blastocysts. Maternal age has a considerable effect, as illustrated by cLBR after the fourth blastocyst transfer of 68.9% (95% CI: 65.8-71.8%) for <35 years; 57.6% (95% CI: 50.4-64.8%) for 35-37 years; 42.9% (95% CI: 37.5-48.4%) for 38-40 years; 16.3% (95% CI: 10.7-21.8%) for 41-42 years; and 13.5% (95% CI: 3.2-23.7%) for >42 years, respectively. In the adjusted logistic regression analysis, the odds for achieving live birth are estimated to decrease for each additional embryo transferred; however, this effect is not statistically significant (OR = 0.91; 95% CI: 0.86-1.07). Female age, as expected, was a significant predictor of implantation rate with subsequent transfers (OR = 0.92; 95% CI: 0.91-0.93). Additionally, being assigned to a blastocyst transfer strategy rather than to a cleavage stage transfer strategy was also a significant predictor (OR = 1.34; 95% CI: 1.20-1.51), as was proportion of embryos classified as excellent or good quality based on predefined morphological criteria out of the total number of embryos previously transferred (OR = 1.21; 95% CI: 1.06-1.38). Implantation rate is also correlated with the response to stimulation (P = 0.016) and the blastocyst formation rate (P < 0.0001). There was no significant difference in LBR after an equal number of previously unsuccessful blastocyst transfers, depending on how many oocyte collection cycles it took to reach that number of blastocysts. LIMITATIONS, REASONS FOR CAUTION: The results are limited by the observational retrospective design, and while regression analyses were adjusted for potential confounding factors, residual confounding may persist, particularly given the considerable heterogeneity in treatments. We did not exclude patients with factors associated with less favourable reproductive outcomes because our goal was to evaluate actual clinical practice. WIDER IMPLICATIONS OF THE FINDINGS: Our data emphasize the potential for successful live birth even after multiple unsuccessful transfers. Factors such as age, embryo quality, response to ovarian stimulation, and rate of blastocyst formation influence outcomes. By addressing these multifaceted influences, our research provides valuable insights and a hopeful outlook for patients undergoing fertility treatment. STUDY FUNDING/COMPETING INTEREST(S): L.D. received a grant from the Agency for Innovation through Science (IWT SB-141441). The funder did not have any role in the study design; data collection, data analysis, and interpretation of data; the writing of the report; nor the decision to submit the paper for publication. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Dhaenens L, Colman R, De Croo I, et al. Cumulative live birth rates of 31 478 untested embryos from 11 463 women challenge traditional recurrent implantation failure definitions. Hum Reprod. 2025. PMID: 40064027. doi:10.1093/humrep/deaf036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。